FINAFLOXACIN

SynDRA canonical compound SYN0028179 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Mechanism of action	bacterial DNA gyrase inhibitor
Indication	chronic obstructive pulmonary disease (COPD) \| cystic fibrosis \| intra-abdominal infections
Disease area	infectious disease \| pulmonary

All known targets

xtoro
finafloxacin hydrochloride
BAY35-3377
finafloxacin HCl
Finafloxacine
Finafloxacino
AL-60371
Xtoro
Finafloxacin hydrochloride
Antibacterial (Helicobacter pylori infection/ bacterial urinary tract infection), Combinature
Finafloxacin (iv, bacterial infection), MerLion/Alcon
Finafloxacin (oral, bacterial infection), MerLion/Alcon
Finafloxacin [INN]
D26OSN9Q4R
CHEBI:85176
Finafloxacin (INN)
8-cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
(-)-8-Cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo(3,4-b)-1,4-oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
7-[(4aS,7aS)-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
gastrochinolon
gastroquinolone
8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
Xtoro (TN)
FINAFLOXACIN [MI]
UNII-D26OSN9Q4R
FINAFLOXACIN [WHO-DD]
SCHEMBL1002869
CHEMBL1908370
GTPL10809
DTXSID10175096
FINAFLOXACIN [ORANGE BOOK]
BCP23882
ZINC3985346
AL60371
CS-5557
DB09047
NCGC00510315-02
(-)-8-Cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo(3,4-b)-1,4-oxazin-6(2H)-yl)-4-oxo-1